Indian Government Awards Grant to Sami Labs

BANGALORE, India—Sami Labs, the research and manufacturing arm of Piscataway, N.J.-based Sabinsa Corp., received funding from the government of India’s Department of Scientific and Industrial Research (DSIR) to perform pilot trials on two novel research projects. The $185,000 grant will be used in part to develop and test a plant-derived cosmetic active, and in part to help develop a novel method for manufacturing resveratrol using Sami’s patented synthetic demethylation strategy.

“Sami Labs considers this sanction by DSIR as a recognition of its sustained efforts to pioneer and explore novel areas of research to improve human health and wellness,” said Muhammed Majeed, Ph.D., founder and CEO of Sabinsa.

In additional news, India’s National Accreditation Board for Testing & Calibration Laboratories successfully audited and accredited Sami Labs’ research and development (R&D) and quality control labs.